Literature DB >> 1613007

Immunologic abnormalities in myelodysplastic syndromes.

T Hamblin1.   

Abstract

In myelodysplastic syndromes, several autoimmune phenomena are more common than expected. Lymphocyte subsets are sometimes abnormal in number and function. Associated lymphoid malignancies and lymphoblastic evolution have occasionally been reported. Molecular studies suggest that the lymphoid system may be involved in the dysplastic process.

Entities:  

Mesh:

Year:  1992        PMID: 1613007

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  11 in total

1.  Co-occurrence of monoclonal gammopathy and myelodysplasia: a retrospective study of fourteen cases.

Authors:  Yataro Yoshida; Shigeru Oguma; Hitoshi Ohno; Yukiharu Nakabo; Tatsuya Katsurada; Masahiro Kawahara; Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2014-04-01       Impact factor: 2.490

2.  Total hearing loss and blindness caused by relapsing polychondritis and myelodysplastic syndrome.

Authors:  Bozena Coha; Ljubica Fustar-Preradovic; Sandra Sekelj; Alen Sekelj
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-17       Impact factor: 2.503

3.  Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes.

Authors:  Asaka Kondo; Taishi Yamashita; Hideto Tamura; Wanhong Zhao; Takashi Tsuji; Masumi Shimizu; Eiji Shinya; Hidemi Takahashi; Koji Tamada; Lieping Chen; Kazuo Dan; Kiyoyuki Ogata
Journal:  Blood       Date:  2010-05-14       Impact factor: 22.113

Review 4.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

Review 5.  Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes.

Authors:  Neal S Young
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

6.  Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.

Authors:  Hiroyuki Kawagoe; Gerard C Grosveld
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

7.  A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement.

Authors:  Chul Won Choi; Yang Jo Chung; Christopher Slape; Peter D Aplan
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

8.  Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.

Authors:  Panagiotis T Diamantopoulos; Maria Michael; Olga Benopoulou; Efthymia Bazanis; George Tzeletas; John Meletis; George Vayopoulos; Nora-Athina Viniou
Journal:  Virol J       Date:  2012-01-03       Impact factor: 4.099

9.  A case of relapsing polychondritis associated with myelodysplastic syndrome with erythroid hypoplasia/aplasia.

Authors:  Seong-Wook Heo; Kyu-Hyun Cho; Jung-Il Ryu; Seung-Hie Chung; Chae-Gi Kim; Sang-Gyung Kim; Jung-Yoon Choe
Journal:  Korean J Intern Med       Date:  2003-12       Impact factor: 2.884

10.  Specific plasma autoantibody reactivity in myelodysplastic syndromes.

Authors:  George I Mias; Rui Chen; Yan Zhang; Kunju Sridhar; Donald Sharon; Li Xiao; Hogune Im; Michael P Snyder; Peter L Greenberg
Journal:  Sci Rep       Date:  2013-11-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.